SPYGX Performance — Spyglass Growth Fund, Institutional Shares
Data updated: 2026-08-26
SPYGX returned −5.63% year to date and +6.53% over one year to Jun 2026. Annualised returns are +22.60% over 3 years and +0.64% over 5 years. Against its US Mid-Cap Growth category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $184, against $152 for the category, and to $107 over one year, against $118. Volatility over the past three years was 28.49% a year. In the 12 months to Jun 2026 the fund took in a net $66.8M, and assets reached $1.00B.
SPYGX Growth of $100
What $100 invested in Spyglass Growth Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Growth category average over the same months.
| Period | SPYGX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $107 | $118 |
| 3 years (Jul 2023 – Jun 2026) | $184 | $152 |
| 5 years (Jul 2021 – Jun 2026) | $103 | $129 |
| Since data start (Jan 2020 – Jun 2026) | $186 | $193 |
SPYGX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −5.63% |
| 1 year | +6.53% |
| 3 years (annualised) | +22.60% |
| 5 years (annualised) | +0.64% |
SPYGX Annual Returns
Calendar-year total returns of Spyglass Growth Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | −5.63% |
| 2025 | +15.74% |
| 2024 | +38.09% |
| 2023 | +54.02% |
| 2022 | −47.16% |
| 2021 | −6.41% |
| 2020 | +61.85% |
SPYGX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −9.3% | −8.1% | −9.3% | +8.1% | +12.8% | +2.3% | — | — | — | — | — | — |
| 2025 | +6.7% | −10.3% | −11.5% | +2.4% | +11.8% | +5.8% | +5.5% | +3.8% | +2.5% | +1.8% | −0.2% | −1.0% |
| 2024 | +0.1% | +6.9% | +4.8% | −7.4% | −0.9% | +0.1% | −2.1% | +9.8% | +5.5% | +1.7% | +25.1% | −7.2% |
| 2023 | +18.2% | −4.6% | −0.4% | −6.0% | +9.7% | +8.8% | +6.6% | −4.0% | −3.6% | −5.8% | +19.3% | +10.3% |
| 2022 | −11.7% | −3.0% | +1.6% | −11.7% | −12.1% | −14.0% | +6.7% | −5.4% | −8.9% | +5.7% | +0.9% | −7.0% |
| 2021 | +0.3% | +3.9% | −3.6% | +3.3% | +0.7% | +6.5% | −3.3% | −0.7% | −3.6% | +3.8% | −10.8% | −1.9% |
| 2020 | +2.6% | −4.6% | −16.2% | +19.3% | +12.9% | +4.4% | +4.9% | +7.5% | −1.5% | −2.1% | +17.0% | +10.2% |
SPYGX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 28.49%
- 3-year Sharpe ratio: 0.64 (vs 4.5% risk-free rate)
- Best month: +25.09% (Nov 2024)
- Worst month: −11.50% (Mar 2025)
SPYGX Fund Flows
Monthly money in and out of Spyglass Growth Fund, from SEC Form N-PORT.
- 12-month net flow: $66.8M
- 12-month gross sales (incl. reinvestments): $374.6M
- Sales ÷ redemptions: 1.22×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $25.1M | $66.9M | −$41.8M |
| May 2026 | $24.0M | $19.8M | $4.2M |
| Apr 2026 | $12.8M | $14.2M | −$1.4M |
| Mar 2026 | $12.4M | $24.7M | −$12.3M |
| Feb 2026 | $17.4M | $24.6M | −$7.2M |
| Jan 2026 | $8.9M | $35.5M | −$26.6M |
| Dec 2025 | $163.4M | $23.7M | $139.6M |
| Nov 2025 | $5.8M | $54.2M | −$48.4M |
| Oct 2025 | $75.5M | $9.7M | $65.8M |
| Sep 2025 | $12.9M | $18.3M | −$5.4M |
| Aug 2025 | $8.2M | $9.0M | −$790K |
| Jul 2025 | $8.0M | $7.0M | $1.0M |
SPYGX Assets Under Management
Net assets of Spyglass Growth Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $1.00B |
| 2026-03-31 | $838.50M |
| 2025-12-31 | $1.16B |
| 2025-09-30 | $993.90M |
| 2025-06-30 | $890.30M |
| 2025-03-31 | $758.43M |
| 2024-12-31 | $951.33M |
| 2024-09-30 | $812.18M |
| 2024-06-30 | $716.81M |
| 2024-03-31 | $813.17M |
| 2023-12-31 | $782.45M |
| 2023-09-30 | $672.18M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.